Investigating the causal relationships between excess adiposity and cardiometabolic health in men and women
Mutie PM, Pomares-Milan H, Atabaki-Pasdar N, et al.
Diabetologia. Pub. online 12 Oct 2022.
Leggi
Statin use and risk of diabetes by subclinical atherosclerosis burden (from a multi-ethnic study of atherosclerosis report)
Rifai MA, Szklo M, Patel J, et al.
Am J Cardiol. 2022;S0002-9149(22)00958-4.
Leggi
AMD – SID | Sessioni di approfondimento
Carissimi Soci, siamo lieti di comunicare che la tradizionale collaborazione e partecipazione AMD - SID ai rispettivi Eventi Nazionali prosegue anche in occasione del 29° Congresso Nazionale 2022. L’appuntamento è come di consueto a Rimini dal 26 al 29 ottobre. Vi segnaliamo le sessioni di approfondimento scientifico ideate insieme: Giovedì…
Leggi
New strategies to improve clinical outcomes for diabetic kidney disease
Forst T, Mathieu C, Giorgino F, et al.
BMC Med. 2022;20(1):337.
Leggi
Characteristics and outcomes of patients with type 1 diabetes admitted with acute coronary syndromes
Nejatian MM, Lan NSR, Yeap BB, et al.
Diabetes Res Clin Pract. 2022;192:110093.
Leggi
Retinal artery occlusion as an early indicator of macrovascular complications in diabetes
Ørskov M, Vorum H , Bjerregaard Larsen T, et al.
Am J Med. 2022;S0002-9343(22)00723-9.
Leggi
Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper
Faggiano A, Mazzilli R, Natalicchio A, Adinolfi V, Argentiero A, Danesi R, D’Oronzo S, Fogli S, Gallo M, Giuffrida D, Gori S, Montagnani M, Ragni A, Renzelli V, Russo A, Silvestris N, Franchina T, Tuveri E, Cinieri S, Colao A, Giorgino F, Zatelli MC
Crit Rev Oncol Hematol. 2022;180:103826.
Leggi
Intermittently scanned continuous glucose monitoring for type 1 diabetes
Leelarathna L, Evans ML, Neupane S, et al.
N Engl J Med. Pub. online 5 Oct 2022.
Leggi
Effects of sodium-glucose cotransporter-2 inhibitors and aldosterone antagonists, in addition to renin-angiotensin system antagonists, on major adverse kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and network meta-analysis
Yang S, Zhao L, Mi Y, He W
Diabetes Obes Metab. 2022;24(11):2159-2168.
Leggi